DOSSIER · 13F-HR · Q1 2026

Euclidean Capital LLC

Euclidean's pension fund based in London, UK $392M in tracked AUM across 10 positions as of Q1 2026.

E
Euclidean·London, UK·Pension Fund
CIK 0001825034 · last filed Mar 31, 2026
Total AUM
$392M
0.6%
vs prior
Holdings
10
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
Top sector
Tech
14% weight
concentration
AI Analysis · Q1 2026 · Q1 2026
Portfolio Overview

Euclidean Capital’s 13F for the quarter ended 2025-09-30 shows a dramatic repositioning. Reported assets decreased from $305.72M to $40.31M, a decline of $265.41M or −86.8% quarter‑over‑quarter. The current reported portfolio contains only 7 positions and is highly concentrated: the top two holdings account for 77.2% of the portfolio value (INDA 47.7%, ORIC 29.5%). The firm’s holdings are now dominated by equities and equity ETFs; there are no fixed income or other asset cla...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
VEU
VANGUARD INTL EQUITY INDEX F
$244M3.2M62.1%
02
VTV
VANGUARD INDEX FDS
$102M520K26.0%
03
INDA
ISHARES TR
$17M370K4.4%
04
ORIC
ORIC PHARMACEUTICALS INC
$13M989K3.2%
05
FHTX
FOGHORN THERAPEUTICS INC
$8M1.6M1.9%
06
PMVP
PMV PHARMACEUTICALS INC
$3M2.6M0.8%
07
ALEC
ALECTOR INC
$3M1.3M0.7%
08
SRZN
SURROZEN INC
$3M88K0.7%
09
TNYA
TENAYA THERAPEUTICS INC
$703,2741.0M0.2%
10
SRZNW
SURROZEN INC
$2,733171K0.0%

Filing history

Filing history loading…